Navigation Links
Longest Trial Ever Confirms Mammograms' Benefits
Date:6/28/2011

By Kathleen Doheny
HealthDay Reporter

TUESDAY, June 28 (HealthDay News) -- Mammography screening reduces breast cancer deaths even more than most experts have long believed, according to a new, large-scale Swedish trial.

In a study with a follow-up of nearly three decades -- the longest ever -- the researchers found that the benefits of the screenings become clearer as the decades roll on.

In fact, most of the benefits occur more than 10 years after mammography begins, and the screenings prevent far more breast cancer deaths than other, shorter studies have found, the report indicated.

"The big news is that if one considers the long-term effects on breast cancer mortality, the absolute benefit of screening in terms of number of lives saved is considerably greater than previously thought," said lead author Stephen W. Duffy, professor of cancer screening at Queen Mary, University of London.

Experts have long debated the best age for mammography screening to begin and how often it should be done.

In the new study, Duffy and colleagues looked at more than 133,000 women ages 40 to 74, living in two Swedish counties.

Researchers assigned them either to a group invited to mammogram screening or a group receiving usual care. The screening phase lasted about seven years. Women aged 40 to 49 got invited to screening every two years; women 50 to 74 every 33 months. The follow-up lasted 29 years.

For every 1,000 to 1,500 mammograms, one breast cancer death was prevented, Duffy's team found.

Other analyses have found, for instance, that for every 2,500 women aged 40 to 49 invited to screening, one death was prevented.

The study, whose authors reported no conflicts of interest, is published in the June 28 online edition of the journal Radiology.

"I was surprised and reassured by how long-lasting the effect was, and how consistent over three decades," Duffy said.

Most of the benefit occurs more than 10 years after the screening starts, he added.

It was not possible to "tease out" the specific benefit of screening women in their 40s, one area of debate, he noted. But other reviews suggest that "although the benefit is smaller, there is still a mortality reduction with screening women in their 40s," Duffy said.

At the end of the study, the investigators found 30 percent fewer breast cancer deaths overall in the group invited to screening compared to those not screened.

There was also a substantial absolute reduction in cancer deaths. At 29 years of follow-up, 34 to 42 years of life were saved for each 1,000 women screened for seven years, and one breast cancer death prevented for every 414 to 519 women. Had the screening continued another 10 years with the same benefits, only 300 screenings would be needed to save one life, the study reported.

In addition, for every 1,000 women screened every two years from ages 40 to 69, about eight to 11 deaths from breast cancer would be prevented, according to the study authors.

Duffy said he does not expect the study results to put to rest the mammography debate.

"There will always be skeptics, who argue that the benefits of screening are too small to justify its financial and human costs," Duffy said. "They have tended to argue this on the basis of deaths prevented during 10 years of screening. Our results show that this argument is invalid, since the majority of the mortality benefit occurs more than 10 years after starting screening."

He and his colleagues noted that the drawbacks of mammography include the risk of radiation exposure and over-diagnosis. However, they wrote that the radiation dose in this trial was much smaller than most modern procedures since it was single-view mammography and over-diagnosis occurred in only a "small fraction" of the cases.

The findings are similar to those from previous studies, said Dr. Virginia Moyer, head of the U.S. Preventive Services Task Force, which in 2009 advised that the decision to start regular screenings every two years before age 50 should be discussed with a woman's doctor. It recommends screening every other year for women aged 50 to 74.

The findings, she said, will not significantly impact the debate.

Moyer added: "When the task force reviewed all evidence for women 40 to 49, it found that about 2,000 to 2,500 women had to be invited to mammography screening to prevent one breast cancer death, which would be 40 to 50 per 100,000 women."

Another expert, Dr. Stephanie Bernik, chief of surgical oncology at Lenox Hill Hospital in New York City, said the study "proves what most clinicians hold to be true: screening mammograms save lives."

More information

To learn more about the screening guidelines, visit the U.S. Preventive Services Task Force.

SOURCES: Virginia A. Moyer, M.D., chair, U.S. Preventive Services Task Force; Stephanie Bernik, M.D., chief of surgical oncology at Lenox Hill Hospital, New York City; Stephen Duffy, M.Sc., professor of cancer screening, Queen Mary University of London, U.K.; June 28, 2011, Radiology, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Women More Likely to Fail Treatment for Atrial Fibrillation
2. Single gene mutation induces endometrial cancer
3. NEJM Publishes Trial Results Demonstrating Bard FLAIR Endovascular Stent Graft Is Superior To Balloon Angioplasty For Failing Dialysis Grafts
4. MCG to conduct first FDA-approved stem cell trial in pediatric cerebral palsy
5. In Tests, Implanted Monitor Detects Atrial Fibrillation
6. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
7. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. WellPoint/Blue Cross Liver Transplant Denial Trial Starts Monday
10. WellPoint/Blue Cross Liver Transplant Denial Trial Begins Today, Illustrates Need for Toughening of White House Reform Plan
11. Mesothelioma Clinical Trials List Offered by IQ Mesothelioma: Search Current Mesothelioma Treatment Options
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Longest Trial Ever Confirms Mammograms'  Benefits
(Date:10/13/2017)... ... October 13, 2017 , ... ProVest Insurance Group, ... Dallas, Miami, and Raleigh regions, is organizing an extended charity drive to benefit ... deadly chromosome abnormality. , After struggling since birth with several health challenges, T.J. ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps ... provides a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... 13, 2017 , ... Ellevate Network, the leading network for professional women, brought ... gender equality at their inaugural Summit in New York City in June. The event ... audience of over 3 million. To watch the Mobilize Women video, click here ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in ... awarded a contract by the Center for Medicare and Medicaid Services (CMS). The ... enterprise use of Agile methodologies in a consistent and high value manner across ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Mich. , Oct. 2, 2017 Diplomat ... 8th Day Software and Consulting, LLC , and ... 8th Day Software, based in Tennessee ... LLC. 8th Day expands EnvoyHealth,s service offerings for health ... development. "In an ...
(Date:10/2/2017)... The Rebound mobile app is poised to become ... tide of prescription drug addiction. The app empowers users to ... stepping down their dosage in a safe, controlled manner while ... the first 100,000 people to sign up will enjoy 3 ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
Breaking Medicine Technology: